| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |